Scarica l'app Stockscreener
0.0361
43.00%
-0.0639
Precedente Chiudi:
$0.10
Aprire:
$0.0397
Volume 24 ore:
22,584
Relative Volume:
66.00
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
$-48.85M
Rapporto P/E:
-0.0156
EPS:
-2.31
Flusso di cassa netto:
$-46.25M
1 W Prestazione:
-43.00%
1M Prestazione:
-89.43%
6M Prestazione:
-99.23%
1 anno Prestazione:
-99.66%
Intervallo 1D:
$0.0361
$0.0399
Intervallo di 1 settimana:
$0.0361
$0.0399
Portata 52W:
$0.0361
$0.0399
Vincerx Pharma Inc Stock (VINC) Company Profile
Nome
Vincerx Pharma Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta VINC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VINC
Vincerx Pharma Inc
|
0.0361 | 0 | 0 | -48.85M | -46.25M | -2.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-01-14 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-11-01 | Iniziato | SVB Leerink | Outperform |
| 2021-09-13 | Iniziato | Laidlaw | Buy |
| 2021-08-25 | Iniziato | B. Riley Securities | Buy |
Vincerx Pharma Inc Borsa (VINC) Ultime notizie
Vincerx Pharma, Inc. Announces Additional Adjournment of - GlobeNewswire
Vincerx Warns Stockholders: Delayed Dissolution Vote Threatens $0.07 Per Share DistributionAction Required - Stock Titan
Vincerx Pharma, Inc. Announces Additional Adjournment of Special MeetingUrges Stockholders to Vote FOR Approval of Dissolution Proposal - Yahoo Finance
Vincerx announces potential distribution of $0.04-$0.08 per share By Investing.com - Investing.com South Africa
Vincerx announces potential distribution of $0.04-$0.08 per share - Investing.com
Vincerx Pharma, Inc. Urges Stockholders to Vote FOR - GlobeNewswire
Vincerx Pharma Stockholders Face Critical July 16 Vote: $0.08 Per Share at Stake in Dissolution Plan - Stock Titan
Vincerx Pharma enters at-the-market equity offering deal - MSN
Vincerx Pharma, Inc. Announces Adjournment of Special MeetingWill Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal - GlobeNewswire
Vincerx Pharma Stockholders Risk Losing All Distribution Value if Dissolution Vote Fails by July 16 - Stock Titan
At a crossroads, biotechs are passing on reverse mergers in 2025 - Endpoints News
TC BioPharm’s $100M Shelf Offering: A Beacon of Resilience in a Collapsing Biotech Landscape - AInvest
Layoff Tracker: IGM Axes 80% of Workforce - BioSpace
Stock Market Recap: Vincerx Pharma Inc (VINC) Concludes at 0.26, a 1.11 Surge/Decline - DWinneX
Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com
Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX
Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com
Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister
Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga
The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com
VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa
VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India
Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India
Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView
Vincerx Pharma announces plan to delist from Nasdaq - TipRanks
Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire
Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan
Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Increases By 99.4% - The AM Reporter
vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia
vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India
Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga
Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada
Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals
Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks
Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times
Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com
Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener
Vincerx Pharma Inc Azioni (VINC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.15%
Capitalizzazione:
|
Volume (24 ore):